ArticleCarcinogenesis2013

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer.

Niranjan Awasthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.